Every US product recall. One feed.

Data refreshed July 28, 2026 · last 180 days

503recalls · last 30 days
40CPSC · last 30 days
394FDA · last 30 days
66NHTSA · last 30 days
3FSIS · last 30 days
3,503in 180-day window

McKesson recalls

RecallSweep is tracking 2 recall notices naming McKesson in the last 180 days, issued by FDA. The most recent is dated July 8, 2026 and the oldest in this window February 18, 2026. They cover Drugs & Supplements. 1 carry a Class I or Do Not Drive designation.

This page lists what the issuing agencies published. It is not a statement about McKesson beyond those notices — open each official notice for the authoritative detail.

Recall notices naming McKesson

2 recalls.

FDA Class II Drugs & Supplements

McKesson: Gemcitabine Injection, 1 g per 26.3 mL (38 mg/mL), 26.3 mL Single-Dose Vial, For Intravenous Infusion ONLY, Rx only, Manufactured by: THYMOORGAN PHAR…

Affected quantity: 74 units

Hazard
Temperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment.

Details
Distribution: Nationwide within the United States. Recall #D-0714-2026, initiated 20260610. Voluntary: Firm initiated.

Products affected
Gemcitabine Injection, 1 g per 26.3 mL (38 mg/mL), 26.3 mL Single-Dose Vial, For Intravenous Infusion ONLY, Rx only, Manufactured by: THYMOORGAN PHARMAZIE GmbH, Schiffgraben 23, 38690 Goslar, Germany; Distributed by: Hikma, Berkeley Heights, NJ 07922. NDC: 0143-9341-01

Recall status
Ongoing

Look up recall #D-0714-2026 in the FDA enforcement database ↗
FDA Class I Drugs & Supplements

McKesson: UDENYCA, pegfilgrastim-cbqv injection, 6 mg/0.6mL Single Dose Prefilled Syringe, Rx only, Manufactured by Accord BioPharma, Inc., 8041 Arco Corporate…

Affected quantity: 116 cartons

Hazard
Temperature Abuse. 116 cartons with specific serial numbers of Lot 2199821, were stored incorrectly in a controlled room temperature environment instead of the required refrigerated environment.

Details
Distribution: Nationwide in the USA. Recall #D-0353-2026, initiated 20260116. Voluntary: Firm initiated.

Products affected
UDENYCA, pegfilgrastim-cbqv injection, 6 mg/0.6mL Single Dose Prefilled Syringe, Rx only, Manufactured by Accord BioPharma, Inc., 8041 Arco Corporate Drive, Suite 200, Raleigh, NC 27617, NDC 69448-025-63

Recall status
Ongoing

Look up recall #D-0353-2026 in the FDA enforcement database ↗

Categories

Agencies

Other brands recalled in the same categories

Browse